April
30
TriSalus Life Sciences Announces $22.0 Million Private Placement and Preliminary Q1 2025 Unaudited Financial Results
Funding Anticipated to Accelerate Applications Already in Use and New Additional Potential Applications Anticipated...
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.